Apellis Pharmaceuticals I...
(APLS)
undefined
undefined%
At close: undefined
33.19
-0.15%
After-hours Dec 13, 2024, 04:15 PM EST
13F Institute Ownership
13F institutions, like mutual and pension funds, are large investors
required by the SEC to disclose their holdings quarterly, significantly
impacting company decisions and stock trends.
As of Sep 30, 2024,
291
Institutions hold a total of
117.08M Apellis Pharmaceuticals Inc. shares, with a combined investment of
$3.38B.
Others: 5.51%
Institutions: 94.49%
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.282
0.28
Call Flow 3,843,200
78%
Put Flow 1,083,900
22%
Top Shareholders
The Top 10 shareholders collectively own 31.56% of the Apellis Pharmaceuticals Inc.| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Wellington Management Group Ll... | 13.23% | 16.39M | +8.84% | 628.67M | 0.11% |
| Ecor1 Capital, LLC | 9.37% | 11.61M | +2.20% | 445.26M | 13.62% |
| Avoro Capital Advisors LLC | 8.97% | 11.11M | +0.00% | 426.22M | 5.68% |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options Data
- Instant access to live options data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.